Toshiba broadens Agfa deal to include CR readersToshiba America Medical Systems of Tustin, CA, and Agfa of Ridgefield Park, NJ, have expanded their value-added reseller agreement to allow Toshiba to add Agfa's ADC computed radiography readers to
Toshiba America Medical Systems of Tustin, CA, and Agfa of Ridgefield Park, NJ, have expanded their value-added reseller agreement to allow Toshiba to add Agfa's ADC computed radiography readers to the Impax PACS products to which Toshiba gained rights in 1996. Toshiba will be the only company to offer both the Impax and ADC product families and will display Agfa Impax technology as part of its networking offerings at the 1997 Radiological Society of North America meeting. Toshiba has rights to sell the Impax and ADC products in the U.S. in situations where it is also selling modality equipment like MRI and CT scanners.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
July 29th 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.